AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 283: E1008-E1015, 2002. First published July 17, 2002; doi:10.1152/ajpendo.00513.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/E1008    most recent
00513.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaffe, C. A.
Right arrow Articles by Watkins, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaffe, C. A.
Right arrow Articles by Watkins, P. B.
Vol. 283, Issue 5, E1008-E1015, November 2002

Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans

Craig A. Jaffe1,2, D. Kim Turgeon3, Kenneth Lown2,3, Roberta Demott-Friberg2, and Paul B. Watkins4

1 Divisions of Endocrinology and Metabolism and 3 Gastroenterology, University of Michigan Medical Center, and 2 Department of Veterans Affairs Medical Center, Ann Arbor, Michigan 48109; and 4 Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599

The importance of gender-specific growth hormone (GH) secretion pattern in the regulation of growth and metabolism has been demonstrated clearly in rodents. We recently showed that GH secretion in humans is also sexually dimorphic. Whether GH secretion pattern regulates the metabolic effects of GH in humans is largely unknown. To address this question, we administered the same daily intravenous dose of GH (0.5 mg · m-2 · day-1) for 8 days in different patterns to nine GH-deficient adults. Each subject was studied on four occasions: protocol 1 (no treatment), protocol 2 (80% daily dose at 0100 and 10% daily dose at 0900 and 1700), protocol 3 (8 equal boluses every 3 h), and protocol 4 (continuous GH infusion). The effects of GH pattern on serum IGF-I, IGF-binding protein (IGFBP)-3, osteocalcin, and urine deoxypyridinoline were measured. Hepatic CYP1A2 and CYP3A4 activities were assessed by the caffeine and erythromycin breath tests, respectively. Protocols 3 and 4 were the most effective in increasing serum IGF-I and IGFBP-3, whereas protocols administering pulsatile GH had the greatest effects on markers of bone formation and resorption. All GH treatments decreased CYP1A2 activity, and the effect was greatest for pulsatile GH. Pulsatile GH decreased, whereas continuous GH infusion increased, CYP3A4 activity. These data demonstrate that GH pulse pattern is an independent parameter of GH action in humans. Gender differences in drug metabolism and, potentially, gender differences in growth rate may be explained by sex-specific GH secretion patterns.

sex characteristics; insulin-like growth factor I; bone; cytochrome P-450


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
D. B. Buckley and C. D. Klaassen
Mechanism of Gender-Divergent UDP-Glucuronosyltransferase mRNA Expression in Mouse Liver and Kidney
Drug Metab. Dispos., April 1, 2009; 37(4): 834 - 840.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Baccam, G. Alonso, T. Costecalde, P. Fontanaud, F. Molino, I. C. A. F. Robinson, P. Mollard, and P.-F. Mery
Dual-Level Afferent Control of Growth Hormone-Releasing Hormone (GHRH) Neurons in GHRH-Green Fluorescent Protein Transgenic Mice
J. Neurosci., February 14, 2007; 27(7): 1631 - 1641.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
C. Gardmo and A. Mode
In vivo transfection of rat liver discloses binding sites conveying GH-dependent and female-specific gene expression
J. Mol. Endocrinol., December 1, 2006; 37(3): 433 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. P. Tuckow, K. R. Rarick, W. J. Kraemer, J. O. Marx, W. C. Hymer, and B. C. Nindl
Nocturnal growth hormone secretory dynamics are altered after resistance exercise: deconvolution analysis of 12-hour immunofunctional and immunoreactive isoforms
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1749 - R1755.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. R. Simon, M. Iwahashi, L.-J. Hu, I. Qadri, I. M. Arias, D. Ortiz, R. Dahl, and E. Sutherland
Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G595 - G608.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Fu, C. M. Damcott, M. Sabra, T. I. Pollin, S. H. Ott, J. Wang, M. J. Garant, J. R. O'Connell, B. D. Mitchell, and A. R. Shuldiner
Polymorphism in the Calsequestrin 1 (CASQ1) Gene on Chromosome 1q21 Is Associated With Type 2 Diabetes in the Old Order Amish
Diabetes, December 1, 2004; 53(12): 3292 - 3299.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Ameen, D. Linden, B.-M. Larsson, A. Mode, A. Holmang, and J. Oscarsson
Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1039 - E1048.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. R. Simon, J. Fortune, M. Iwahashi, I. Qadri, and E. Sutherland
Multihormonal regulation of hepatic sinusoidal Ntcp gene expression
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G782 - G794.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Lamba, J. Lamba, K. Yasuda, S. Strom, J. Davila, M. L. Hancock, J. D. Fackenthal, P. K. Rogan, B. Ring, S. A. Wrighton, et al.
Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 906 - 922.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online